Close up shot of cannabis flower

ANTG secures 10-year deal to supply Germany $92 million in medical cannabis


Medical cannabis company Australian Natural Therapeutics Group (ANTG) has signed a deal that will see the company supplying large quantities of medical cannabis to Germany over the next ten years.

ANTG is NSW’s first producer of cannabis oil. They were granted a license to produce large quantities of cannabis oil in December 2020

Now, the company has announced a deal that will see them exporting $92 million in medical cannabis to Germany, where it will be available to Germans who are prescribed cannabis medications by a doctor. 

The export deal will continue until 2031, with ANTG shipping 2 tonnes of dried cannabis flower to Germany over the next 18 months. The cannabis flower will be fully Australian-grown.

Australian Natural Therapeutics Group ANTG Logo

ANTG believe the exporting deal will be positive for Australia’s medical cannabis industry, as Germany is the world’s third-largest medical cannabis market – behind Canada and the United States. 

Germany’s medical cannabis market is expected to be worth as much as $12.4 billion by 2028, according to ANTG. 

Germany currently sources 80% of their cannabis from German-companies, with exported cannabis coming from the Netherlands and Canada. ANTG will be the second Australian company to export medical cannabis into Germany after Althea Group announced a deal with Nimbus Health in November last year

However, other Australian medical cannabis companies are expected to begin exporting products overseas, as a bill passed in June 2020 gives medical cannabis a ‘Legitimate Export of Narcotic Products’ stamp. This will also allow cannabis to be sold in Europe, Canada, the US, China and parts of South-East Asia.

Growth in cannabis exporting leaves Australia poised to become a global leader in medical cannabis supply, according to comments from Health Minister Greg Hunt in 7News

Australia’s gold-standard regulation of medicinal cannabis products, coupled with a premium agricultural and manufacturing industry, means we are well-positioned to become a preferred supplier.

Hunt believes this will have a positive benefit on Australia’s economy, as it has the potential to create jobs and boost economic growth nationwide. 
Australia’s medical cannabis industry is expected to be worth $1.5 billion by 2024.

Stay informed with the latest cannabis news in Australia.


Latest from National

Stay informed with the latest cannabis news in Australia.

Stay informed with the latest cannabis news in Australia.

Go to Top